Annotation Detail for CYP17A1
Basic Information Top
Gene Symbol: | CYP17A1 ( CPT7,CYP17,P450C17,S17AH ) |
---|---|
Gene Full Name: | cytochrome P450, family 17, subfamily A, polypeptide 1 |
Band: | 10q24.32 |
Quick Links | Entrez ID:1586; OMIM: 609300; Uniprot ID:CP17A_HUMAN; ENSEMBL ID: ENSG00000148795; HGNC ID: 2593 |
Relate to Another Database: | SFARIGene; denovo-db |
Pathway ID | Pathway Name |
---|---|
PWY66-381 | glucocorticoid biosynthesis |
PWY66-378 | androgen biosynthesis |
Pathway ID | Pathway Name |
---|---|
hsa00140 | Steroid hormone biosynthesis |
hsa01100 | Metabolic pathways |
Pathway ID | Pathway Name |
---|---|
Hormone biosynthesis | |
Metabolism of lipids and lipoproteins | |
Biological oxidations |
No data |
No data |
Pathway ID | Pathway Name |
---|---|
500195 | Endogenous sterols |
500772 | Steroid hormones |
500776 | Androgen biosynthesis |
500774 | Glucocorticoid biosynthesis |
500832 | Metabolism of steroid hormones and vitamin D |
Desease ID | Desease Name |
---|---|
Inherited disorders of lipid/glycolipid metabolism | |
H00216 | Congenital adrenal hyperplasia |
Genetic disorders |
No data |
Desease Name |
---|
rheumatoid arthritis |
ovarian cancer |
oral cancer |
Parkinson's disease |
polycystic ovary syndrome |
menarche |
colorectal cancer |
prostate cancer prostate specific antigen |
CARDIOVASCULAR |
height |
urinary calculus |
endometriosis |
serum androgen concentrations |
Osteoporosis |
menopause |
hormone disturbance |
bone size |
prostate cancer |
male breast cancer |
prostatic hyperplasia |
Bone Mineral Density |
CANCER |
liver disease |
systolic blood pressure |
Osteoporosis, Postmenopausal |
intrauterine growth |
serum estrogen and progesterone concentrations |
bone density |
endometrial cancer |
Polycystic ovaries and premature male pattern baldness |
breast cancer |
Lymphoma, Non-Hodgkin |
IMMUNE |
NEUROLOGICAL |
pregnancy loss, recurrent |
METABOLIC |
spondyloarthropathies |
Body Weight |
stature |
acne |
sex hormones |
REPRODUCTION |
INFECTION |
Overweight |
prostate volume/histology endocrine patterns |
testosterone |
Insulin Resistance |
Desease Name |
---|
Parkinson's disease |
Systolic blood pressure |
Desease Name |
---|
17-alpha-hydroxylase/17,20-lyase deficiency |
17,20-lyase deficiency, isolated |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C003582 | 11-hydroxyandrostenedione | 11-hydroxyandrostenedione results in decreased expression of CYP17A1 mRNA | decreases expression | 15858796 |
C483839 | 2,2',3,4,4',5',6-heptabromodiphenyl ether | 2,2',3,4,4',5',6-heptabromodiphenyl ether results in decreased activity of CYP17A1 protein | decreases activity | 16828825 |
C404910 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in decreased expression of CYP17A1 mRNA | decreases expression | 11509743 |
C404910 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane | [Estradiol co-treated with 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane] results in decreased expression of CYP17A1 mRNA | affects cotreatment|decreases expression | 11509743 |
C016403 | 2,4-dinitrotoluene | 2,4-dinitrotoluene affects the expression of CYP17A1 mRNA | affects expression | 21346803 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in decreased activity of CYP17A1 protein | decreases activity | 15703266 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CYP17A1 mRNA | decreases expression | 15703266 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP17A1 mRNA | increases expression | 16216300 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP17A1 mRNA | increases expression | 12781204 |
C439677 | 3-hydroxy-17-(1H-1,2,3-triazol-1-yl)androsta-5,16-diene | 3-hydroxy-17-(1H-1,2,3-triazol-1-yl)androsta-5,16-diene results in decreased activity of CYP17A1 protein | decreases activity | 15555909 |
C500627 | 3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene | 3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene results in decreased activity of CYP17A1 protein | decreases activity | 15828836 |
C495960 | 3-hydroxy-17-(imidazol-1-yl)androsta-5,16-diene | 3-hydroxy-17-(imidazol-1-yl)androsta-5,16-diene results in decreased activity of CYP17A1 protein | decreases activity | 15555909 |
C494060 | 4-nitro-3-phenylphenol | [4-nitro-3-phenylphenol co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of CYP17A1 protein | affects cotreatment|decreases expression | 18336853 |
D000082 | Acetaminophen | Acetaminophen affects the expression of CYP17A1 mRNA | affects expression | 17562736 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of CYP17A1 mRNA | decreases expression | 17202762 |
D000324 | Adrenocorticotropic Hormone | Adrenocorticotropic Hormone results in increased expression of CYP17A1 mRNA | increases expression | 15625562 |
D043582 | 5-alpha-Dihydroprogesterone | CYP17A1 protein results in increased hydroxylation of 5-alpha-Dihydroprogesterone | increases hydroxylation | 14522586 |
D006907 | 17-alpha-Hydroxypregnenolone | CYP17A1 protein affects the chemical synthesis of 17-alpha-Hydroxypregnenolone | affects chemical synthesis | 16030167 |
D006907 | 17-alpha-Hydroxypregnenolone | CYP17A1 protein affects the metabolism of 17-alpha-Hydroxypregnenolone | affects metabolic processing | 16030167 |
D006907 | 17-alpha-Hydroxypregnenolone | CYP17A1 protein results in decreased acetylation of 17-alpha-Hydroxypregnenolone | decreases acetylation | 15562394 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of CYP17A1 mRNA | affects expression | 16483693 |
D000728 | Androgens | CYP17A1 protein affects the chemical synthesis of Androgens | affects chemical synthesis | 15761033 |
D000728 | Androgens | CYP17A1 protein affects the chemical synthesis of Androgens | affects chemical synthesis | 14624484 |
D000728 | Androgens | CYP17A1 protein affects the chemical synthesis of Androgens | affects chemical synthesis | 15862817 |
C000152 | androsta-5,16-dien-3 beta-ol | CYP17A1 protein affects the chemical synthesis of androsta-5,16-dien-3 beta-ol | affects chemical synthesis | 12631293 |
C000152 | androsta-5,16-dien-3 beta-ol | CYP17A1 protein affects the chemical synthesis of androsta-5,16-dien-3 beta-ol | affects chemical synthesis | 12631293 |
D000735 | Androstenedione | Androstenedione results in decreased expression of CYP17A1 mRNA | decreases expression | 15625562 |
D000735 | Androstenedione | Androstenedione results in decreased expression of CYP17A1 mRNA | decreases expression | 15625562 |
D000735 | Androstenedione | CYP17A1 protein affects the chemical synthesis of Androstenedione | affects chemical synthesis | 14522586 16030167 15562394 |
D000735 | Androstenedione | TNF protein inhibits the reaction [CYP17A1 protein affects the chemical synthesis of Androstenedione] | affects chemical synthesis|decreases reaction | 16030167 |
D000735 | Androstenedione | CYP17A1 protein affects the chemical synthesis of Androstenedione | affects chemical synthesis | 15555913 |
D000735 | Androstenedione | CYP17A1 protein affects the chemical synthesis of Androstenedione | affects chemical synthesis | 15640159 |
D000738 | Androsterone | CYP17A1 protein affects the chemical synthesis of Androsterone | affects chemical synthesis | 14522586 |
C103016 | antalarmin | antalarmin results in decreased expression of CYP17A1 mRNA | decreases expression | 16014403 |
C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [FGF19 protein results in decreased expression of CYP17A1 mRNA] | decreases expression|decreases reaction | 16269825 |
C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one results in increased expression of CYP17A1 mRNA | increases expression | 16269825 |
D001151 | Arsenic | CYP17A1 protein affects the metabolism of Arsenic | affects metabolic processing | 18682255 |
C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of CYP17A1 mRNA | decreases expression | 18630931 |
C104416 | astressin | astressin results in decreased expression of CYP17A1 mRNA | decreases expression | 16014403 |
C006780 | bisphenol A | bisphenol A results in increased expression of CYP17A1 mRNA | increases expression | 17706920 |
C006780 | bisphenol A | bisphenol A results in decreased expression of CYP17A1 mRNA | decreases expression | 20144698 15901920 |
C006780 | bisphenol A | bisphenol A results in decreased expression of CYP17A1 protein | decreases expression | 20144698 14605012 |
C006780 | bisphenol A | [bisphenol A results in decreased expression of CYP17A1 protein] which results in decreased abundance of Testosterone | decreases abundance|decreases expression | 14605012 |
C006780 | bisphenol A | bisphenol A results in increased expression of CYP17A1 mRNA | increases expression | 18191889 |
C006780 | bisphenol A | [bisphenol A results in increased expression of CYP17A1 mRNA] which affects the abundance of Testosterone | affects abundance|increases expression | 18191889 |
D015124 | 8-Bromo Cyclic Adenosine Monophosphate | [4-nitro-3-phenylphenol co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of CYP17A1 protein | affects cotreatment|decreases expression | 18336853 |
D002220 | Carbamazepine | Carbamazepine results in decreased activity of CYP17A1 protein | decreases activity | 15730543 |
D002220 | Carbamazepine | Carbamazepine results in decreased expression of CYP17A1 mRNA | decreases expression | 19566492 |
D002784 | Cholesterol | CYP17A1 protein affects the chemical synthesis of Cholesterol | affects chemical synthesis | 15761033 |
C029010 | cinnamic acid | cinnamic acid analog results in decreased activity of CYP17A1 protein | decreases activity | 15072549 |
D002995 | Clofibric Acid | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CYP17A1 mRNA | affects cotreatment|affects expression | 17602206 |
D003314 | Corn Oil | Corn Oil affects the expression of CYP17A1 mRNA | affects expression | 16360708 |
C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in decreased activity of CYP17A1 protein | decreases activity | 18495385 |
D003687 | Dehydroepiandrosterone | Dehydroepiandrosterone results in decreased expression of CYP17A1 mRNA | decreases expression | 15625562 |
D003687 | Dehydroepiandrosterone | CYP17A1 protein affects the chemical synthesis of Dehydroepiandrosterone | affects chemical synthesis | 16030167 15562394 |
D003687 | Dehydroepiandrosterone | Dehydroepiandrosterone results in decreased expression of CYP17A1 mRNA | decreases expression | 15625562 |
D003687 | Dehydroepiandrosterone | CYP17A1 protein affects the chemical synthesis of Dehydroepiandrosterone | affects chemical synthesis | 15666818 |
D003687 | Dehydroepiandrosterone | CYP17A1 protein affects the chemical synthesis of Dehydroepiandrosterone | affects chemical synthesis | 15934942 |
D003687 | Dehydroepiandrosterone | CYP17A1 protein affects the metabolism of Dehydroepiandrosterone | affects metabolic processing | 15261307 |
D003687 | Dehydroepiandrosterone | CYP17A1 protein affects the chemical synthesis of Dehydroepiandrosterone | affects chemical synthesis | 15640159 |
D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of CYP17A1 mRNA | decreases expression | 15987825 15141095 14617579 |
D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of CYP17A1 protein | decreases expression | 14617579 15141095 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CYP17A1 mRNA | affects cotreatment|affects expression | 17602206 |
D004054 | Diethylstilbestrol | Diethylstilbestrol affects the expression of CYP17A1 mRNA | affects expression | 15196701 |
D004054 | Diethylstilbestrol | Diethylstilbestrol affects the expression of CYP17A1 protein | affects expression | 15196701 |
D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in decreased expression of CYP17A1 mRNA | decreases expression | 17072980 |
C035144 | drospirenone | [Ethinyl Estradiol co-treated with drospirenone] results in decreased activity of CYP17A1 protein | affects cotreatment|decreases activity | 17418832 |
D004958 | Estradiol | ESR1 protein affects the reaction [Estradiol results in decreased expression of CYP17A1 mRNA] | affects reaction|decreases expression | 17158782 |
D004958 | Estradiol | [Estradiol co-treated with 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane] results in decreased expression of CYP17A1 mRNA | affects cotreatment|decreases expression | 11509743 |
D004958 | Estradiol | [Estradiol co-treated with Methoxychlor metabolite] results in decreased expression of CYP17A1 mRNA | affects cotreatment|decreases expression | 11509743 |
D004958 | Estradiol | Estradiol results in decreased expression of CYP17A1 mRNA | decreases expression | 11509743 17158782 |
D004958 | Estradiol | Estradiol results in decreased expression of CYP17A1 mRNA | decreases expression | 20144698 |
D004958 | Estradiol | Estradiol results in decreased expression of CYP17A1 protein | decreases expression | 20144698 |
D004967 | Estrogens | CYP17A1 promoter polymorphism affects the metabolism of Estrogens | affects metabolic processing | 16850246 |
D004967 | Estrogens | CYP17A1 protein affects the chemical synthesis of Estrogens | affects chemical synthesis | 15341023 |
D002393 | Estrogens, Catechol | CYP17A1 protein polymorphism results in increased chemical synthesis of Estrogens, Catechol | increases chemical synthesis | 15288375 |
D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with drospirenone] results in decreased activity of CYP17A1 protein | affects cotreatment|decreases activity | 17418832 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of CYP17A1 mRNA | affects expression | 14976129 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of CYP17A1 mRNA | increases expression | 12072388 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of CYP17A1 mRNA | decreases expression | 15858796 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of CYP17A1 mRNA | affects expression | 17222921 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of CYP17A1 mRNA | decreases expression | 12655037 16140622 15901920 15834898 |
C026098 | etiracetam | etiracetam results in decreased expression of CYP17A1 mRNA | decreases expression | 19566492 |
D017316 | Fadrozole | Fadrozole results in decreased activity of CYP17A1 protein | decreases activity | 15771425 15743198 |
D005485 | Flutamide | Flutamide results in increased expression of CYP17A1 mRNA | increases expression | 11509743 |
D005485 | Flutamide | Flutamide affects the expression of CYP17A1 mRNA | affects expression | 17222921 |
D005485 | Flutamide | Flutamide results in increased expression of CYP17A1 mRNA | increases expression | 14967917 |
D005576 | Forskolin | Forskolin results in increased expression of CYP17A1 mRNA | increases expression | 15625562 |
D005576 | Forskolin | Forskolin results in increased expression of CYP17A1 mRNA | increases expression | 15625562 15886251 17080404 |
D005576 | Forskolin | Lindane inhibits the reaction [Forskolin results in increased expression of CYP17A1 mRNA] | decreases reaction|increases expression | 17080404 |
D005576 | Forskolin | TGFB1 protein inhibits the reaction [Forskolin results in increased expression of CYP17A1 mRNA] | decreases reaction|increases expression | 15625562 |
D005576 | Forskolin | AGT protein inhibits the reaction [Forskolin results in increased expression of CYP17A1 protein] | decreases reaction|increases expression | 15666819 |
D005576 | Forskolin | Forskolin results in increased expression of CYP17A1 protein | increases expression | 15666819 |
D005576 | Forskolin | Tetradecanoylphorbol Acetate inhibits the reaction [Forskolin results in increased expression of CYP17A1 protein] | decreases reaction|increases expression | 15666819 |
D005576 | Forskolin | AGT protein inhibits the reaction [Forskolin results in increased expression of CYP17A1 protein] | decreases reaction|increases expression | 15666819 |
D005576 | Forskolin | Forskolin results in increased expression of CYP17A1 protein | increases expression | 15666819 |
D005576 | Forskolin | Tetradecanoylphorbol Acetate inhibits the reaction [Forskolin results in increased expression of CYP17A1 protein] | decreases reaction|increases expression | 15666819 |
C070081 | fulvestrant | fulvestrant results in increased expression of CYP17A1 mRNA | increases expression | 17158782 |
C056933 | fumonisin B1 | fumonisin B1 results in decreased expression of CYP17A1 mRNA | decreases expression | 16221962 |
C001277 | geldanamycin | geldanamycin results in increased expression of CYP17A1 mRNA | increases expression | 15711029 |
D019833 | Genistein | Genistein results in decreased expression of CYP17A1 mRNA | decreases expression | 15901920 |
D012739 | Gonadal Steroid Hormones | CYP17A1 protein affects the chemical synthesis of Gonadal Steroid Hormones | affects chemical synthesis | 16045239 |
D006064 | Gonadotropins, Equine | Gonadotropins, Equine inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA] | decreases expression|decreases reaction | 19276399 |
D055768 | Halogenated Diphenyl Ethers | Halogenated Diphenyl Ethers metabolite results in decreased expression of CYP17A1 mRNA | decreases expression | 18313098 |
D055768 | Halogenated Diphenyl Ethers | Halogenated Diphenyl Ethers metabolite results in increased expression of CYP17A1 mRNA | increases expression | 18313098 |
D006063 | Chorionic Gonadotropin | Chorionic Gonadotropin results in increased expression of CYP17A1 mRNA | increases expression | 15930178 |
C029424 | hydrazine | hydrazine results in increased expression of CYP17A1 mRNA | increases expression | 15370871 |
D019326 | 17-alpha-Hydroxyprogesterone | CYP17A1 protein affects the chemical synthesis of 17-alpha-Hydroxyprogesterone | affects chemical synthesis | 16030167 |
D019326 | 17-alpha-Hydroxyprogesterone | CYP17A1 protein affects the metabolism of 17-alpha-Hydroxyprogesterone | affects metabolic processing | 16030167 |
D019326 | 17-alpha-Hydroxyprogesterone | TNF protein inhibits the reaction [CYP17A1 protein affects the metabolism of 17-alpha-Hydroxyprogesterone] | affects metabolic processing|decreases reaction | 16030167 |
D006908 | Hydroxyprogesterones | CYP17A1 protein results in decreased acetylation of Hydroxyprogesterones | decreases acetylation | 15562394 |
D007189 | Indans | Indans results in decreased activity of CYP17A1 protein | decreases activity | 15743198 |
D007529 | Isoflavones | Isoflavones results in increased activity of CYP17A1 protein | increases activity | 15698548 |
D007654 | Ketoconazole | Ketoconazole results in decreased activity of CYP17A1 protein | decreases activity | 15771425 15743198 |
D007654 | Ketoconazole | Ketoconazole results in decreased activity of CYP17A1 protein | decreases activity | 15934942 |
D007657 | Ketone Bodies | Ketone Bodies results in decreased expression of CYP17A1 mRNA | decreases expression | 15469884 |
C047781 | lamotrigine | lamotrigine results in decreased activity of CYP17A1 protein | decreases activity | 15730543 |
D001556 | Lindane | Lindane inhibits the reaction [Forskolin results in increased expression of CYP17A1 mRNA] | decreases reaction|increases expression | 17080404 |
C013598 | methoxyacetic acid | methoxyacetic acid results in increased expression of CYP17A1 mRNA | increases expression | 18486176 |
D008731 | Methoxychlor | [Estradiol co-treated with Methoxychlor metabolite] results in decreased expression of CYP17A1 mRNA | affects cotreatment|decreases expression | 11509743 |
D008731 | Methoxychlor | Methoxychlor metabolite results in decreased expression of CYP17A1 mRNA | decreases expression | 11509743 |
D008797 | Metyrapone | Metyrapone results in increased expression of CYP17A1 mRNA | increases expression | 15265784 |
C016599 | mono-(2-ethylhexyl)phthalate | mono-(2-ethylhexyl)phthalate results in decreased expression of CYP17A1 mRNA | decreases expression | 16809437 |
C016599 | mono-(2-ethylhexyl)phthalate | mono-(2-ethylhexyl)phthalate results in increased expression of CYP17A1 mRNA | increases expression | 16809437 |
C406082 | monomethylarsonous acid | monomethylarsonous acid results in decreased expression of CYP17A1 mRNA | decreases expression | 20024957 |
D009281 | Naphthalenes | Naphthalenes analog results in decreased activity of CYP17A1 protein | decreases activity | 15449729 |
C042763 | olive oil | olive oil analog affects the expression of CYP17A1 mRNA | affects expression | 17349074 |
D010126 | Ozone | Ozone results in decreased expression of CYP17A1 mRNA | decreases expression | 16183385 |
C093973 | PD 98059 | PD 98059 results in decreased expression of CYP17A1 mRNA | decreases expression | 15817663 |
C093973 | PD 98059 | PD 98059 results in increased activity of CYP17A1 protein | increases activity | 17138841 |
C093973 | PD 98059 | PD 98059 results in increased expression of CYP17A1 mRNA | increases expression | 17138841 |
C093973 | PD 98059 | pioglitazone inhibits the reaction [PD 98059 results in increased activity of CYP17A1 protein] | decreases reaction|increases activity | 17138841 |
C093973 | PD 98059 | pioglitazone inhibits the reaction [PD 98059 results in increased expression of CYP17A1 mRNA] | decreases reaction|increases expression | 17138841 |
C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of CYP17A1 mRNA | increases expression | 16221955 |
C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of CYP17A1 mRNA | increases expression | 17681415 |
C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of CYP17A1 mRNA | increases expression | 16221955 |
D010634 | Phenobarbital | Phenobarbital results in increased expression of CYP17A1 mRNA | increases expression | 19270015 |
C060836 | pioglitazone | pioglitazone inhibits the reaction [PD 98059 results in increased activity of CYP17A1 protein] | decreases reaction|increases activity | 17138841 |
C060836 | pioglitazone | pioglitazone inhibits the reaction [PD 98059 results in increased expression of CYP17A1 mRNA] | decreases reaction|increases expression | 17138841 |
C060836 | pioglitazone | pioglitazone results in decreased activity of CYP17A1 protein | decreases activity | 15072549 17138841 |
C060836 | pioglitazone | pioglitazone results in decreased expression of CYP17A1 mRNA | decreases expression | 17138841 |
C006253 | pirinixic acid | pirinixic acid results in increased expression of CYP17A1 mRNA | increases expression | 20059764 18301758 |
C006253 | pirinixic acid | PPARA protein promotes the reaction [pirinixic acid results in increased expression of CYP17A1 mRNA] | increases expression|increases reaction | 20059764 |
D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Pregnenolone binds to CYP17A1 protein] | affects binding|decreases reaction | 15666820 |
D011075 | Polybrominated Biphenyls | Polybrominated Biphenyls analog results in decreased activity of CYP17A1 protein | decreases activity | 16828825 |
D011280 | Pregnanolone | CYP17A1 protein results in increased hydroxylation of Pregnanolone analog | increases hydroxylation | 14522586 |
D011284 | Pregnenolone | CYP17A1 protein results in increased hydroxylation of Pregnenolone | increases hydroxylation | 15459122 |
D011284 | Pregnenolone | CYP17A1 protein affects the metabolism of Pregnenolone | affects metabolic processing | 15993106 |
D011284 | Pregnenolone | CYP17A1 protein affects the metabolism of Pregnenolone | affects metabolic processing | 16030167 16054388 |
D011284 | Pregnenolone | CYP17A1 protein mutant form results in increased hydroxylation of Pregnenolone | increases hydroxylation | 15844475 |
D011284 | Pregnenolone | CYP17A1 protein results in increased hydroxylation of Pregnenolone | increases hydroxylation | 15562394 15844475 |
D011284 | Pregnenolone | CYP17A1 protein results in increased hydroxylation of Pregnenolone | increases hydroxylation | 15459122 |
D011284 | Pregnenolone | Plant Extracts inhibits the reaction [Pregnenolone binds to CYP17A1 protein] | affects binding|decreases reaction | 15666820 |
D011284 | Pregnenolone | CYP17A1 protein results in increased hydroxylation of Pregnenolone | increases hydroxylation | 15640159 |
C045362 | prochloraz | prochloraz results in decreased activity of CYP17A1 protein | decreases activity | 19733639 |
C045362 | prochloraz | prochloraz results in decreased expression of CYP17A1 mRNA | decreases expression | 19733639 |
C045362 | prochloraz | prochloraz results in increased expression of CYP17A1 mRNA | increases expression | 19767443 |
C045362 | prochloraz | prochloraz results in decreased activity of CYP17A1 protein | decreases activity | 17369198 16375936 17234647 |
C045362 | prochloraz | [prochloraz results in decreased activity of CYP17A1 protein] which results in decreased chemical synthesis of Testosterone | decreases activity|decreases chemical synthesis | 17369198 17234647 |
C045362 | prochloraz | prochloraz results in increased expression of CYP17A1 mRNA | increases expression | 16375936 |
C045362 | prochloraz | prochloraz results in increased expression of CYP17A1 protein | increases expression | 16375936 |
D011374 | Progesterone | CYP17A1 protein affects the metabolism of Progesterone | affects metabolic processing | 16054388 16030167 |
D011374 | Progesterone | CYP17A1 protein binds to and affects the metabolism of Progesterone | affects binding|affects metabolic processing | 14522586 |
D011374 | Progesterone | CYP17A1 protein results in increased hydroxylation of Progesterone | increases hydroxylation | 15562394 |
D011374 | Progesterone | CYP17A1 protein affects the metabolism of Progesterone | affects metabolic processing | 15261307 |
D011374 | Progesterone | CYP17A1 protein results in increased hydroxylation of Progesterone | increases hydroxylation | 15640159 |
C031280 | pyrazole | pyrazole results in decreased expression of CYP17A1 mRNA | decreases expression | 17945193 |
D019289 | Pyruvic Acid | Pyruvic Acid promotes the reaction [CTBP1 protein binds to CYP17A1 promoter] | affects binding|increases reaction | 18184656 |
D019289 | Pyruvic Acid | Pyruvic Acid promotes the reaction [CTBP2 protein binds to CYP17A1 promoter] | affects binding|increases reaction | 18184656 |
D019289 | Pyruvic Acid | Pyruvic Acid promotes the reaction [NR5A1 protein binds to CYP17A1 promoter] | affects binding|increases reaction | 18184656 |
D019289 | Pyruvic Acid | Pyruvic Acid results in increased expression of CYP17A1 mRNA | increases expression | 18184656 |
D012176 | Retinoids | Retinoids results in increased expression of CYP17A1 mRNA | increases expression | 15914525 |
C089730 | rosiglitazone | rosiglitazone results in decreased activity of CYP17A1 protein | decreases activity | 15072549 |
D013110 | Sphingosine | Sphingosine results in increased expression of CYP17A1 mRNA | increases expression | 15666826 |
C060506 | sphingosine 1-phosphate | sphingosine 1-phosphate results in increased expression of CYP17A1 mRNA | increases expression | 15666826 |
D013739 | Testosterone | Testosterone results in decreased expression of CYP17A1 mRNA | decreases expression | 15625562 |
D013739 | Testosterone | Testosterone results in decreased expression of CYP17A1 mRNA | decreases expression | 15625562 |
D013739 | Testosterone | AMH protein inhibits the reaction [CYP17A1 protein affects the chemical synthesis of Testosterone] | affects chemical synthesis|decreases reaction | 14630719 |
D013739 | Testosterone | CYP17A1 protein affects the chemical synthesis of Testosterone | affects chemical synthesis | 15932923 |
D013739 | Testosterone | [bisphenol A results in decreased expression of CYP17A1 protein] which results in decreased abundance of Testosterone | decreases abundance|decreases expression | 14605012 |
D013739 | Testosterone | [bisphenol A results in increased expression of CYP17A1 mRNA] which affects the abundance of Testosterone | affects abundance|increases expression | 18191889 |
D013739 | Testosterone | [prochloraz results in decreased activity of CYP17A1 protein] which results in decreased chemical synthesis of Testosterone | decreases activity|decreases chemical synthesis | 17369198 17234647 |
D043343 | Testosterone Propionate | Testosterone Propionate results in decreased expression of CYP17A1 mRNA | decreases expression | 15601916 |
C517826 | tetrabrominated diphenyl ether 47 | tetrabrominated diphenyl ether 47 analog results in decreased activity of CYP17A1 protein | decreases activity | 16828825 |
D013749 | Tetrachlorodibenzodioxin | Gonadotropins, Equine inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA] | decreases expression|decreases reaction | 19276399 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA | decreases expression | 17291543 19276399 16960034 19490992 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 protein | decreases expression | 17291543 19276399 |
D013752 | Tetracycline | Tetracycline results in decreased expression of CYP17A1 mRNA | decreases expression | 16917069 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate inhibits the reaction [Forskolin results in increased expression of CYP17A1 protein] | decreases reaction|increases expression | 15666819 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in decreased expression of CYP17A1 protein | decreases expression | 15666819 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate inhibits the reaction [Forskolin results in increased expression of CYP17A1 protein] | decreases reaction|increases expression | 15666819 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in decreased expression of CYP17A1 protein | decreases expression | 15666819 |
D013764 | Tetrahydronaphthalenes | Tetrahydronaphthalenes results in decreased activity of CYP17A1 protein | decreases activity | 15743198 |
C020809 | tetrathiomolybdate | tetrathiomolybdate results in increased expression of CYP17A1 mRNA | increases expression | 16731777 |
C052342 | topiramate | topiramate results in decreased activity of CYP17A1 protein | decreases activity | 15730543 |
D014212 | Tretinoin | Tretinoin results in increased expression of CYP17A1 mRNA | increases expression | 16621909 |
D014212 | Tretinoin | Tretinoin results in decreased expression of CYP17A1 mRNA | decreases expression | 14960491 |
D014260 | Triclosan | Triclosan results in decreased expression of CYP17A1 mRNA | decreases expression | 19118620 |
C057693 | troglitazone | troglitazone results in decreased activity of CYP17A1 protein | decreases activity | 15072549 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of CYP17A1 mRNA | decreases expression | 19566492 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of CYP17A1 mRNA | increases expression | 14576182 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of CYP17A1 protein | increases expression | 14576182 |
C025643 | vinclozolin | vinclozolin results in increased expression of CYP17A1 mRNA | increases expression | 14967917 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000014 | Abnormalities, Drug-Induced | Carbamazepine | 17.58 | 8986270 | |
MESH:D000014 | Abnormalities, Drug-Induced | methoxyacetic acid | 17.58 | 12805644 1761407 1761404 3652986 15959878 | |
MESH:D000014 | Abnormalities, Drug-Induced | Phenobarbital | 17.58 | 6195326 | |
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 17.58 | 15322242 14514962 11752688 | |
MESH:D000014 | Abnormalities, Drug-Induced | Valproic Acid | 17.58 | 8875741 | |
MESH:D000015 | Abnormalities, Multiple | Valproic Acid | 3.13 | 19490988 | |
MESH:D000138 | Acidosis | Ammonium Chloride | 2.69 | 18287403 | |
MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 3.05 | 17505938 | |
MESH:D055371 | Acute Lung Injury | pirinixic acid | 2.31 | 18653653 | |
MESH:D000230 | Adenocarcinoma | arsenic trioxide | 9.96 | 19825857 11798837 | |
MESH:D000230 | Adenocarcinoma | Dimethylnitrosamine | 9.96 | 16033868 | |
MESH:D000230 | Adenocarcinoma | Estradiol | 9.96 | 11473722 | |
MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 9.96 | 14692618 | |
MESH:D000230 | Adenocarcinoma | Genistein | 9.96 | 11473722 | |
MESH:D000236 | Adenoma | Diethylnitrosamine | 5.01 | 6695378 10737359 | |
MESH:D000236 | Adenoma | Dimethylnitrosamine | 5.01 | 19555203 | |
MESH:D018248 | Adenoma, Liver Cell | 3,4,5,3',4'-pentachlorobiphenyl | 23.51 | 16628245 | |
MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 23.51 | 18056438 19061943 17162532 19052882 17620307 16434500 | |
MESH:D018248 | Adenoma, Liver Cell | Phenobarbital | 23.51 | 17620307 | |
MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 23.51 | 16434500 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 23.51 | 16835633 | |
OMIM:202110 | ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY | marker/mechanism | |||
MESH:D000309 | Adrenal Insufficiency | Dehydroepiandrosterone | 4.90 | 17302879 | |
MESH:D018246 | Adrenocortical Adenoma | Arsenic | 4.32 | 17306315 | |
MESH:D000382 | Agricultural Workers' Diseases | Lindane | 3.52 | 12661182 | |
MESH:D000437 | Alcoholism | topiramate | 4.31 | 17925516 18552399 19331489 | |
MESH:D000505 | Alopecia | Isoflavones | 7.15 | 17569567 | |
MESH:D000505 | Alopecia | Tretinoin | 7.15 | 15955085 | |
MESH:D000544 | Alzheimer Disease | Androgens | 6.98 | 17182789 17917157 | |
MESH:D000544 | Alzheimer Disease | Ozone | 6.98 | 15513908 | |
MESH:D000544 | Alzheimer Disease | Plant Extracts | 6.98 | 16962711 | |
MESH:D000544 | Alzheimer Disease | rosiglitazone | 6.98 | 19621015 | |
MESH:D000550 | Amblyopia | Valproic Acid | 4.34 | 17688650 | |
MESH:D000686 | Amyloidosis | Diethylstilbestrol | 3.64 | 15469931 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 2.18 | 11748828 | |
MESH:D000799 | Angioedema | Acetaminophen | 2.95 | 10982225 | |
MESH:D000987 | Antisocial Personality Disorder | Testosterone | 4.96 | 7506515 | |
MESH:D001008 | Anxiety Disorders | etiracetam | 10.85 | 19265183 | |
MESH:D001008 | Anxiety Disorders | Valproic Acid | 10.85 | 17497229 | |
MESH:D001008 | Anxiety Disorders | vinclozolin | 10.85 | 19015723 | |
MESH:D020261 | Arsenic Poisoning | Arsenic | 2.54 | 12569548 18414634 16835338 16251483 | |
MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 2.61 | 11256880 | |
MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 8.76 | 15885639 | |
MESH:D001169 | Arthritis, Experimental | Plant Extracts | 8.76 | 14686799 | |
MESH:D001169 | Arthritis, Experimental | Tretinoin | 8.76 | 16412693 | |
MESH:D001172 | Arthritis, Rheumatoid | Ozone | 3.63 | 15570426 | |
MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 3.63 | 16292516 | |
MESH:D001249 | Asthma | Ozone | 3.71 | 16373670 17854713 | |
MESH:D001249 | Asthma | Tretinoin | 3.71 | 16456186 | |
MESH:D050197 | Atherosclerosis | Arsenic | 7.90 | 12928151 19371607 | |
MESH:D050197 | Atherosclerosis | Cholesterol | 7.90 | 16632123 | |
MESH:D050197 | Atherosclerosis | olive oil | 7.90 | 16216721 | |
MESH:D001284 | Atrophy | fulvestrant | 4.01 | 11514358 | |
MESH:D001321 | Autistic Disorder | Acetaminophen | 2.79 | 18445737 | |
MESH:D001321 | Autistic Disorder | etiracetam | 2.79 | 19232924 19265183 | |
MESH:D001321 | Autistic Disorder | pioglitazone | 2.79 | 17207275 | |
MESH:D001321 | Autistic Disorder | tetrabrominated diphenyl ether 47 | 2.79 | 19211157 | |
MESH:D001321 | Autistic Disorder | Valproic Acid | 2.79 | 17157402 18985861 17688650 17507914 20603192 18316065 15238991 18558336 18775368 16609825 19460635 18177632 18396377 18940202 19232924 | |
MESH:D001471 | Barrett Esophagus | Tretinoin | 3.56 | 16935849 | |
MESH:D001714 | Bipolar Disorder | Carbamazepine | 9.13 | 17594078 20046352 | |
MESH:D001714 | Bipolar Disorder | etiracetam | 9.13 | 19265183 | |
MESH:D001714 | Bipolar Disorder | Valproic Acid | 9.13 | 20046352 17594078 | |
MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 15.44 | 16206674 | |
MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 15.44 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 15.44 | 12125929 | |
MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 15.44 | 16206674 16197459 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.90 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 5.91 | 15746008 | |
MESH:D001848 | Bone Diseases, Developmental | Valproic Acid | 5.91 | 8888407 | |
MESH:D001862 | Bone Resorption | bisphenol A | 3.07 | 11985600 | |
MESH:D001919 | Bradycardia | antalarmin | 5.49 | 16710322 | |
MESH:D020201 | Brain Hemorrhage, Traumatic | Progesterone | 4.44 | 17868700 | |
MESH:D001930 | Brain Injuries | Pregnanolone | 8.76 | 15380490 15665606 | |
MESH:D001930 | Brain Injuries | Progesterone | 8.76 | 15665606 15380490 15845082 | |
MESH:D002545 | Brain Ischemia | Plant Extracts | 3.86 | 16041641 | |
MESH:D001943 | Breast Neoplasms | Androgens | 9.86 | 17018787 | |
MESH:D001943 | Breast Neoplasms | bisphenol A | 9.86 | 17123778 | |
MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 9.86 | 17474063 | |
MESH:D001943 | Breast Neoplasms | Diethylstilbestrol | 9.86 | 15324884 17129689 | |
MESH:D001943 | Breast Neoplasms | Estradiol | 9.86 | 19861407 17018787 16675129 12948864 17261762 17289903 14630087 18497071 | |
MESH:D001943 | Breast Neoplasms | Estrogens, Catechol | 9.86 | 17261777 | |
MESH:D001943 | Breast Neoplasms | fulvestrant | 9.86 | 18984771 | |
MESH:D001943 | Breast Neoplasms | Genistein | 9.86 | 17200150 16873071 16541309 | |
MESH:D001943 | Breast Neoplasms | Lindane | 9.86 | 14688026 | |
MESH:D001943 | Breast Neoplasms | Progesterone | 9.86 | 15562024 16175315 17614352 | |
MESH:D001943 | Breast Neoplasms | Retinoids | 9.86 | 17368321 17491551 19340624 | |
MESH:D001943 | Breast Neoplasms | Testosterone | 9.86 | 17261762 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 9.86 | 20435547 | |
MESH:D001943 | Breast Neoplasms | Tretinoin | 9.86 | 16166294 16443354 16873071 | |
MESH:D016535 | Bronchial Hyperreactivity | Ozone | 2.96 | 14754758 16777450 19059883 18315731 17626835 15516495 18417511 | |
MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 3.71 | 16813970 | |
MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 3.51 | 11589617 | |
MESH:D002057 | Burns, Chemical | Plant Extracts | 4.44 | 9625245 | |
MESH:D002100 | Cachexia | Ozone | 3.86 | 16183385 | |
MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 3.58 | 16111702 | |
MESH:D002277 | Carcinoma | Dimethylnitrosamine | 5.94 | 19555203 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 5.94 | 16835633 | |
MESH:D002280 | Carcinoma, Basal Cell | Arsenic | 3.02 | 15504454 17687452 | |
MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 4.26 | 16168501 | |
MESH:D006528 | Carcinoma, Hepatocellular | marker/mechanism | 15341023 | ||
MESH:D006528 | Carcinoma, Hepatocellular | 2,4-dinitrotoluene | 25.73 | 16705839 | |
MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 25.73 | 3084413 | |
MESH:D006528 | Carcinoma, Hepatocellular | anthra(1,9-cd)pyrazol-6(2H)-one | 25.73 | 19418558 | |
MESH:D006528 | Carcinoma, Hepatocellular | Arsenic | 25.73 | 16507464 17306315 | |
MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 25.73 | 14691202 11135700 15073043 15553829 16217749 | |
MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 25.73 | 19383236 16935385 19107877 16569478 17428255 20514400 18665156 16328049 10737359 19539802 19418558 16698587 19394651 16830150 20512989 18506893 20935162 19701751 20084675 18978308 18971187 19919837 21159647 16502159 16807293 17138121 16779866 20727157 11831363 16540662 18785209 18788625 20432363 17978847 18494052 19171122 20524982 19208518 18056438 16878318 16681979 17173139 18691550 10672840 17162532 20214788 20101231 17055752 19822196 16288022 19519916 3084413 20007298 18393292 17761372 18210153 19052882 3581430 19335982 | |
MESH:D006528 | Carcinoma, Hepatocellular | Diethylstilbestrol | 25.73 | 16924424 15948411 | |
MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 25.73 | 16924424 | |
MESH:D006528 | Carcinoma, Hepatocellular | Estrogens | 25.73 | 15341023 | |
MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 25.73 | 16924424 | |
MESH:D006528 | Carcinoma, Hepatocellular | Phenobarbital | 25.73 | 17173139 6705139 20007298 20935162 1701930 | |
MESH:D006528 | Carcinoma, Hepatocellular | Plant Extracts | 25.73 | 18834353 | |
MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 25.73 | 1917145 | |
MESH:D002278 | Carcinoma in Situ | bisphenol A | 4.11 | 17123778 | |
MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 3.98 | 19014326 | |
MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 3.33 | 12490120 | |
MESH:D002294 | Carcinoma, Squamous Cell | Arsenic | 7.81 | 18922899 15504454 17687452 | |
MESH:D002294 | Carcinoma, Squamous Cell | Dimethylnitrosamine | 7.81 | 16033868 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 7.81 | 18922899 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 7.81 | 16096774 16051514 | |
MESH:D002295 | Carcinoma, Transitional Cell | Arsenic | 3.30 | 18640142 | |
MESH:D006332 | Cardiomegaly | Plant Extracts | 5.08 | 17645561 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 5.08 | 16120746 18850075 18670907 | |
MESH:D009202 | Cardiomyopathies | tetrathiomolybdate | 4.75 | 16242529 | |
MESH:D002318 | Cardiovascular Diseases | Arsenic | 12.02 | 19152805 15738583 17938729 | |
MESH:D002318 | Cardiovascular Diseases | Genistein | 12.02 | 16332659 | |
MESH:D002318 | Cardiovascular Diseases | Isoflavones | 12.02 | 17689850 | |
MESH:D002318 | Cardiovascular Diseases | olive oil | 12.02 | 16216721 | |
MESH:D002340 | Carotid Artery Diseases | Arsenic | 3.54 | 18022660 16973168 | |
MESH:D002386 | Cataract | Acetaminophen | 5.24 | 10977129 | |
MESH:D002386 | Cataract | Tretinoin | 5.24 | 17460283 | |
MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 7.54 | 2727394 7505956 17174075 21159647 | |
MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 7.54 | 18566989 | |
MESH:D002471 | Cell Transformation, Neoplastic | monomethylarsonous acid | 7.54 | 19716837 | |
MESH:D002493 | Central Nervous System Diseases | Phenobarbital | 3.39 | 4080065 | |
MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 3.71 | 16129372 | |
MESH:D002659 | Child Development Disorders, Pervasive | Androstenedione | 10.48 | 21398041 | |
MESH:D002659 | Child Development Disorders, Pervasive | Testosterone | 10.48 | 20678186 | |
MESH:D002659 | Child Development Disorders, Pervasive | topiramate | 10.48 | 15650499 | |
MESH:D002659 | Child Development Disorders, Pervasive | Valproic Acid | 10.48 | 20734317 | |
MESH:D018281 | Cholangiocarcinoma | 3,4,5,3',4'-pentachlorobiphenyl | 11.81 | 16628245 | |
MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 11.81 | 19052882 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 11.81 | 16835633 | |
MESH:D002779 | Cholestasis | Ethinyl Estradiol | 5.43 | 16919318 17333356 16105132 17110522 11677210 17681005 15861022 | |
MESH:D002779 | Cholestasis | pirinixic acid | 5.43 | 19176532 | |
MESH:D002822 | Choriocarcinoma | Tretinoin | 4.26 | 16461808 | |
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 4.20 | 12621046 15340226 15668235 8697196 16354765 | |
MESH:D002972 | Cleft Palate | Tretinoin | 4.20 | 9407595 | |
MESH:D003092 | Colitis | Tretinoin | 2.86 | 17035595 | |
MESH:D003110 | Colonic Neoplasms | Genistein | 2.11 | 17182828 | |
MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 2.57 | 20501625 | |
MESH:D015179 | Colorectal Neoplasms | Isoflavones | 2.57 | 17116718 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 7.01 | 17141729 14669216 | |
MESH:D000013 | Congenital Abnormalities | Triclosan | 7.01 | 19283420 | |
MESH:D023903 | Coronary Restenosis | arsenic trioxide | 3.35 | 12609071 | |
MESH:D019465 | Craniofacial Abnormalities | 3,4,5,3',4'-pentachlorobiphenyl | 7.21 | 17686920 | |
MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 7.21 | 10525206 | |
MESH:D019465 | Craniofacial Abnormalities | Carbamazepine | 7.21 | 9014606 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 7.21 | 10048152 20055451 15322242 | |
MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 7.21 | 9125849 17551590 9664655 10589399 8800419 16925845 14991402 9142499 9224671 9211117 | |
MESH:D019465 | Craniofacial Abnormalities | Valproic Acid | 7.21 | 8888407 17688650 16575769 | |
MESH:D016638 | Critical Illness | Androgens | 10.78 | 16670151 | |
MESH:D016638 | Critical Illness | Estrogens | 10.78 | 16670151 | |
MESH:D003456 | Cryptorchidism | Dibutyl Phthalate | 14.52 | 16037377 | |
MESH:D003456 | Cryptorchidism | Diethylstilbestrol | 14.52 | 16002989 12952375 | |
MESH:D003456 | Cryptorchidism | vinclozolin | 14.52 | 14966744 | |
MESH:D003490 | Cyanosis | 2,4-dinitrotoluene | 3.16 | 18551238 | |
MESH:D003550 | Cystic Fibrosis | pioglitazone | 4.16 | 19747007 | |
MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 3.28 | 15213294 | |
MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 1.93 | 18249437 | |
MESH:D003920 | Diabetes Mellitus | rosiglitazone | 3.54 | 17446233 | |
MESH:D003922 | Diabetes Mellitus, Type 1 | Dehydroepiandrosterone | 3.34 | 16616286 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 15.90 | 20387270 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 15.90 | 16647724 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | pioglitazone | 15.90 | 16023994 12642470 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | rosiglitazone | 15.90 | 12642470 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 15.90 | 17107852 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | topiramate | 15.90 | 16979414 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | troglitazone | 15.90 | 16023994 | |
MESH:D003925 | Diabetic Angiopathies | troglitazone | 4.78 | 12601628 | |
MESH:D003928 | Diabetic Nephropathies | Estradiol | 6.66 | 19279558 | |
MESH:D003928 | Diabetic Nephropathies | Plant Extracts | 6.66 | 19706694 | |
MESH:D003929 | Diabetic Neuropathies | Pregnanolone | 9.59 | 17187935 | |
MESH:D003929 | Diabetic Neuropathies | Progesterone | 9.59 | 17187935 | |
OMIM:607208 | DRAVET SYNDROME | Carbamazepine | 4.59 | 11748493 | |
MESH:D004342 | Drug Hypersensitivity | Carbamazepine | 3.80 | 20216337 15057820 16538176 16538175 | |
MESH:D056486 | Drug-Induced Liver Injury | 2,4-dinitrotoluene | 27.47 | 18551238 21346803 | |
MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 27.47 | 16227642 10915739 11834606 19420014 19416960 2444490 18071297 15619225 11461765 12594235 14986274 10663392 12705907 12540782 15968718 14550746 11421492 11529661 17522070 19164858 16781746 19923254 14725611 17906064 16177239 11287661 12958197 18713872 16485898 11743745 16081117 12153990 19370779 19739265 17562736 11739529 16109766 19085960 12392966 10774834 16393943 | |
MESH:D056486 | Drug-Induced Liver Injury | Carbamazepine | 27.47 | 17465707 | |
MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 27.47 | 19107877 | |
MESH:D056486 | Drug-Induced Liver Injury | Dimethylnitrosamine | 27.47 | 8172417 | |
MESH:D056486 | Drug-Induced Liver Injury | fumonisin B1 | 27.47 | 16221962 | |
MESH:D056486 | Drug-Induced Liver Injury | Ketoconazole | 27.47 | 18289764 | |
MESH:D056486 | Drug-Induced Liver Injury | pyrazole | 27.47 | 12499123 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 27.47 | 20420201 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetracycline | 27.47 | 17522070 | |
MESH:D056486 | Drug-Induced Liver Injury | troglitazone | 27.47 | 14986274 | |
MESH:D056486 | Drug-Induced Liver Injury | Valproic Acid | 27.47 | 1733752 19641884 | |
MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 3.20 | 19426721 | |
MESH:D004362 | Drug Toxicity | Carbamazepine | 6.09 | 20216337 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 6.09 | 11462148 | |
MESH:D004421 | Dystonia | Phenobarbital | 7.71 | 1851702 | |
MESH:D004421 | Dystonia | Valproic Acid | 7.71 | 1851702 | |
MESH:D004487 | Edema | perfluorooctanoic acid | 16.95 | 17259670 12083418 | |
MESH:D004487 | Edema | pirinixic acid | 16.95 | 12083418 | |
MESH:D004487 | Edema | Plant Extracts | 16.95 | 12787963 | |
MESH:D004487 | Edema | rosiglitazone | 16.95 | 12083418 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 16.95 | 12711302 11000095 | |
MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 16.95 | 16716910 9599246 11698051 7812673 15177302 8273558 8113982 | |
MESH:D004489 | Edema, Cardiac | 3,4,5,3',4'-pentachlorobiphenyl | 15.96 | 17686920 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 15.96 | 15322242 16714409 18230668 | |
MESH:D004489 | Edema, Cardiac | Tretinoin | 15.96 | 18230668 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Carbamazepine | 10.67 | 17654737 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 10.67 | 12538720 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Progesterone | 10.67 | 17692515 | |
MESH:D004714 | Endometrial Hyperplasia | Diethylstilbestrol | 8.98 | 16402032 | |
MESH:D004714 | Endometrial Hyperplasia | Genistein | 8.98 | 16402032 | |
MESH:D016889 | Endometrial Neoplasms | Diethylstilbestrol | 16.64 | 15700306 16804899 | |
MESH:D016889 | Endometrial Neoplasms | Estradiol | 16.64 | 18566989 11473722 19148513 | |
MESH:D016889 | Endometrial Neoplasms | Estrogens, Catechol | 16.64 | 18566989 | |
MESH:D016889 | Endometrial Neoplasms | Genistein | 16.64 | 11473722 | |
MESH:D016889 | Endometrial Neoplasms | Tretinoin | 16.64 | 16569247 | |
MESH:D004715 | Endometriosis | Progesterone | 6.34 | 16134523 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 6.34 | 10568697 9294722 | |
MESH:D004719 | Endomyocardial Fibrosis | Plant Extracts | 4.79 | 15268973 | |
MESH:D004816 | Epidermal Necrolysis, Toxic | Carbamazepine | 9.29 | 19915237 16538176 20485159 16415921 18855540 | |
MESH:D004816 | Epidermal Necrolysis, Toxic | lamotrigine | 9.29 | 20235791 | |
MESH:D004831 | Epilepsies, Myoclonic | Carbamazepine | 19.42 | 17275665 | |
MESH:D004831 | Epilepsies, Myoclonic | lamotrigine | 19.42 | 17275665 | |
MESH:D004831 | Epilepsies, Myoclonic | Phenobarbital | 19.42 | 3659116 | |
MESH:D004831 | Epilepsies, Myoclonic | Valproic Acid | 19.42 | 17275665 3659116 | |
MESH:D004828 | Epilepsies, Partial | Carbamazepine | 22.21 | 16628512 17116037 15008574 | |
MESH:D004828 | Epilepsies, Partial | etiracetam | 22.21 | 19265183 | |
MESH:D004828 | Epilepsies, Partial | lamotrigine | 22.21 | 17116037 | |
MESH:D004828 | Epilepsies, Partial | Phenobarbital | 22.21 | 3922381 11558140 | |
MESH:D004828 | Epilepsies, Partial | Valproic Acid | 22.21 | 16628512 3922381 | |
MESH:D004827 | Epilepsy | Carbamazepine | 18.84 | 18234410 7988514 17465707 17178248 19620853 19439326 19700373 821787 9014606 20417680 | |
MESH:D004827 | Epilepsy | lamotrigine | 18.84 | 19668019 | |
MESH:D004827 | Epilepsy | Phenobarbital | 18.84 | 20417680 | |
MESH:D004827 | Epilepsy | Plant Extracts | 18.84 | 19700373 19439326 | |
MESH:D004827 | Epilepsy | topiramate | 18.84 | 19148780 | |
MESH:D004827 | Epilepsy | Valproic Acid | 18.84 | 18234410 20417680 | |
MESH:D004832 | Epilepsy, Absence | etiracetam | 10.74 | 19265183 | |
MESH:D004832 | Epilepsy, Absence | Phenobarbital | 10.74 | 6401628 | |
MESH:D004832 | Epilepsy, Absence | Valproic Acid | 10.74 | 7562514 6254150 6426943 | |
MESH:D017029 | Epilepsy, Complex Partial | Carbamazepine | 14.48 | 7750514 | |
MESH:D017029 | Epilepsy, Complex Partial | Phenobarbital | 14.48 | 7750514 | |
MESH:D017029 | Epilepsy, Complex Partial | Valproic Acid | 14.48 | 7750514 | |
MESH:D004833 | Epilepsy, Temporal Lobe | lamotrigine | 11.93 | 16499746 | |
MESH:D004833 | Epilepsy, Temporal Lobe | topiramate | 11.93 | 16499746 | |
MESH:D004830 | Epilepsy, Tonic-Clonic | Carbamazepine | 18.39 | 15276670 3659116 | |
MESH:D004830 | Epilepsy, Tonic-Clonic | etiracetam | 18.39 | 19265183 | |
MESH:D004830 | Epilepsy, Tonic-Clonic | Phenobarbital | 18.39 | 3659116 | |
MESH:D004830 | Epilepsy, Tonic-Clonic | Valproic Acid | 18.39 | 3659116 | |
MESH:C535500 | Epileptic encephalopathy, Lennox-Gastaut type | etiracetam | 5.94 | 19265183 | |
MESH:D004916 | Erythromelalgia | Carbamazepine | 4.84 | 19549232 | |
MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 4.22 | 16302075 | |
MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 3.68 | 12903497 | |
MESH:D004938 | Esophageal Neoplasms | Dimethylnitrosamine | 3.68 | 17016578 | |
MESH:D005076 | Exanthema | Carbamazepine | 4.59 | 20485159 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 6.51 | 11564622 | |
MESH:D005124 | Eye Abnormalities | Tretinoin | 6.51 | 16938888 9664655 | |
MESH:D015785 | Eye Diseases, Hereditary | Retinoids | 5.14 | 16968212 | |
MESH:D005234 | Fatty Liver | arsenic trioxide | 29.51 | 15073043 | |
MESH:D005234 | Fatty Liver | Diethylnitrosamine | 29.51 | 20387270 21071580 | |
MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 29.51 | 15345470 | |
MESH:D005234 | Fatty Liver | pirinixic acid | 29.51 | 19236843 20131406 | |
MESH:D005234 | Fatty Liver | Plant Extracts | 29.51 | 15975614 | |
MESH:D005234 | Fatty Liver | rosiglitazone | 29.51 | 19196556 | |
MESH:D005234 | Fatty Liver | Tetracycline | 29.51 | 19224547 16917069 | |
MESH:D005234 | Fatty Liver | Valproic Acid | 29.51 | 19224547 14986274 | |
MESH:D052776 | Female Urogenital Diseases | Diethylstilbestrol | 3.05 | 16002989 16611131 15751030 16513791 16534752 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 2.60 | 11858732 | |
MESH:D005315 | Fetal Diseases | Valproic Acid | 3.99 | 16575769 | |
MESH:D005317 | Fetal Growth Retardation | Valproic Acid | 3.29 | 18558336 8888407 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 5.80 | 20067830 | |
MESH:D005355 | Fibrosis | Tretinoin | 5.80 | 17994277 | |
MESH:D005391 | Firesetting Behavior | Testosterone | 4.96 | 7506515 | |
MESH:D005532 | Foot Deformities, Congenital | methoxyacetic acid | 4.88 | 3652986 | |
MESH:D005534 | Foot Diseases | Arsenic | 4.66 | 6392382 | |
MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 3.42 | 16904648 | |
MESH:D005756 | Gastritis | Acetaminophen | 2.79 | 16983495 | |
MESH:D030342 | Genetic Diseases, Inborn | vinclozolin | 4.05 | 16973722 | |
MESH:D005832 | Genital Diseases, Male | vinclozolin | 4.40 | 16417039 | |
MESH:D005833 | Genital Neoplasms, Female | Diethylstilbestrol | 4.07 | 16452187 | |
MESH:D005909 | Glioblastoma | Genistein | 11.82 | 16598420 | |
MESH:D005909 | Glioblastoma | perfluorooctane sulfonic acid | 11.82 | 17162496 | |
MESH:D005909 | Glioblastoma | Testosterone | 11.82 | 17162496 | |
MESH:D005909 | Glioblastoma | Tretinoin | 11.82 | 17312396 | |
MESH:D005923 | Glomerulosclerosis, Focal Segmental | pioglitazone | 4.51 | 16687628 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.70 | 10696789 | |
MESH:D006258 | Head and Neck Neoplasms | Retinoids | 6.21 | 17368321 | |
MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 6.21 | 16096774 | |
MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 4.26 | 16084493 | |
MESH:D006330 | Heart Defects, Congenital | 3,4,5,3',4'-pentachlorobiphenyl | 8.08 | 17686920 20471113 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 8.08 | 10048152 11294989 | |
MESH:D006330 | Heart Defects, Congenital | Tretinoin | 8.08 | 9664655 14991402 | |
MESH:D006333 | Heart Failure | pirinixic acid | 5.21 | 20558911 | |
MESH:D006333 | Heart Failure | Plant Extracts | 5.21 | 18097624 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.54 | 11000095 | |
MESH:D006527 | Hepatolenticular Degeneration | tetrathiomolybdate | 5.42 | 17276780 | |
MESH:D006529 | Hepatomegaly | fumonisin B1 | 18.20 | 16221962 | |
MESH:D006529 | Hepatomegaly | perfluorooctanoic acid | 18.20 | 3609246 | |
MESH:D006529 | Hepatomegaly | Phenobarbital | 18.20 | 16109766 | |
MESH:D006529 | Hepatomegaly | pirinixic acid | 18.20 | 19772884 19176532 18467677 16221962 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 18.20 | 15340226 16120746 12621046 | |
MESH:D006558 | Herpes Genitalis | Estradiol | 4.14 | 15709030 | |
MESH:D006561 | Herpes Simplex | Plant Extracts | 3.76 | 10715843 | |
MESH:D006628 | Hirsutism | Androgens | 10.68 | 17019078 16914592 | |
MESH:D006628 | Hirsutism | Testosterone | 10.68 | 17019078 | |
MESH:D015658 | HIV Infections | Plant Extracts | 3.15 | 12878215 | |
MESH:D019584 | Hot Flashes | Estradiol | 12.16 | 17088409 | |
MESH:D019584 | Hot Flashes | Isoflavones | 12.16 | 14716179 17290160 | |
MESH:D019584 | Hot Flashes | Plant Extracts | 12.16 | 17454163 16566672 14716179 | |
MESH:D006849 | Hydrocephalus | Valproic Acid | 3.99 | 17688650 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 3.15 | 16354765 16959395 15340226 8697196 18606429 | |
MESH:D006930 | Hyperalgesia | Acetaminophen | 12.78 | 16870215 | |
MESH:D006930 | Hyperalgesia | perfluorooctanoic acid | 12.78 | 12083418 | |
MESH:D006930 | Hyperalgesia | rosiglitazone | 12.78 | 12083418 | |
MESH:D006930 | Hyperalgesia | Tretinoin | 12.78 | 16870215 | |
MESH:D017588 | Hyperandrogenism | Androgens | 14.87 | 17019078 | |
MESH:D017588 | Hyperandrogenism | Flutamide | 14.87 | 15356085 | |
MESH:D017588 | Hyperandrogenism | Testosterone | 14.87 | 17019078 | |
MESH:D006937 | Hypercholesterolemia | Cholesterol | 4.18 | 16933029 | |
MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 3.71 | 16778211 | |
MESH:D006943 | Hyperglycemia | pirinixic acid | 2.41 | 20558911 | |
MESH:D020138 | Hyperhomocysteinemia | Carbamazepine | 7.30 | 10459572 | |
MESH:D020138 | Hyperhomocysteinemia | Plant Extracts | 7.30 | 16484555 | |
MESH:D017488 | Hyperkeratosis, Epidermolytic | Arsenic | 3.67 | 17050553 | |
MESH:D006949 | Hyperlipidemias | Plant Extracts | 3.66 | 15268973 15975614 | |
MESH:D006965 | Hyperplasia | Carbamazepine | 8.46 | 18773962 | |
MESH:D006965 | Hyperplasia | Diethylstilbestrol | 8.46 | 12960047 14722030 | |
MESH:D006968 | Hypersensitivity, Delayed | Corn Oil | 4.92 | 11484837 | |
MESH:D006973 | Hypertension | Arsenic | 3.79 | 11953799 16076760 9931084 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 3.79 | 18850075 18670907 | |
MESH:D006987 | Hypesthesia | Arsenic | 4.66 | 16093927 | |
MESH:D007006 | Hypogonadism | Testosterone | 3.91 | 12002444 | |
MESH:D007018 | Hypopituitarism | Testosterone | 5.31 | 17426086 | |
MESH:D007021 | Hypospadias | Diethylstilbestrol | 8.39 | 16002989 | |
MESH:D007021 | Hypospadias | Ethinyl Estradiol | 8.39 | 16569931 16945680 | |
MESH:D007174 | Impulse Control Disorders | Testosterone | 4.96 | 7506515 | |
MESH:D020244 | Infarction, Middle Cerebral Artery | Progesterone | 3.54 | 15869954 | |
MESH:D007246 | Infertility | Diethylstilbestrol | 3.52 | 15036965 | |
MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 2.65 | 12013081 | |
MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 14.35 | 17937319 | |
MESH:D007248 | Infertility, Male | fulvestrant | 14.35 | 11514358 | |
MESH:D007248 | Infertility, Male | Methoxychlor | 14.35 | 11955947 16467254 | |
MESH:D007248 | Infertility, Male | Triclosan | 14.35 | 20821571 | |
MESH:D007248 | Infertility, Male | vinclozolin | 14.35 | 16467254 | |
MESH:D007249 | Inflammation | Diethylnitrosamine | 22.31 | 18785209 | |
MESH:D007249 | Inflammation | perfluorooctanoic acid | 22.31 | 12083418 | |
MESH:D007249 | Inflammation | pioglitazone | 22.31 | 16908763 | |
MESH:D007249 | Inflammation | Plant Extracts | 22.31 | 15997105 12787963 16366677 19332304 | |
MESH:D007249 | Inflammation | Progesterone | 22.31 | 15869954 | |
MESH:D007249 | Inflammation | rosiglitazone | 22.31 | 12083418 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 22.31 | 12878042 12200463 | |
MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 22.31 | 11698051 8273558 15177302 7812673 7562506 | |
MESH:D007249 | Inflammation | Triclosan | 22.31 | 9584910 20507366 | |
MESH:D007333 | Insulin Resistance | bisphenol A | 12.43 | 16393666 | |
MESH:D007333 | Insulin Resistance | Estradiol | 12.43 | 16393666 16627594 | |
MESH:D007333 | Insulin Resistance | pirinixic acid | 12.43 | 16306350 | |
MESH:D007333 | Insulin Resistance | rosiglitazone | 12.43 | 16306350 | |
MESH:D007410 | Intestinal Diseases | Tretinoin | 2.92 | 17994277 | |
MESH:D007414 | Intestinal Neoplasms | Plant Extracts | 3.84 | 12351151 12584176 12628509 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 7.27 | 16580747 | |
MESH:D007569 | Jaw Abnormalities | Tretinoin | 7.27 | 15992940 17551590 | |
MESH:D007642 | Keratosis | Arsenic | 4.11 | 12749816 16930632 | |
MESH:D007674 | Kidney Diseases | Acetaminophen | 3.97 | 12587719 15629191 | |
MESH:D007674 | Kidney Diseases | Estradiol | 3.97 | 15618244 | |
MESH:D007680 | Kidney Neoplasms | 2,4-dinitrotoluene | 8.21 | 16705839 | |
MESH:D007680 | Kidney Neoplasms | Diethylstilbestrol | 8.21 | 15003126 16762066 14681315 | |
MESH:D007680 | Kidney Neoplasms | Estradiol | 8.21 | 15610895 | |
MESH:D007859 | Learning Disorders | Cholesterol | 7.28 | 17134702 | |
MESH:D007859 | Learning Disorders | Diethylstilbestrol | 7.28 | 17184923 | |
MESH:D016773 | Leishmaniasis, Cutaneous | Ketoconazole | 3.96 | 8889330 2166429 19744259 1311351 | |
MESH:D007898 | Leishmaniasis, Visceral | Ketoconazole | 3.85 | 11332679 | |
MESH:D007938 | Leukemia | arsenic trioxide | 7.40 | 15070760 | |
MESH:D007938 | Leukemia | Genistein | 7.40 | 17468513 18980019 | |
MESH:D007938 | Leukemia | Tretinoin | 7.40 | 17143497 | |
MESH:D004915 | Leukemia, Erythroblastic, Acute | troglitazone | 5.25 | 16085563 | |
MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 3.00 | 17077332 12560223 | |
MESH:D007948 | Leukemia, Monocytic, Acute | anthra(1,9-cd)pyrazol-6(2H)-one | 14.64 | 16972261 | |
MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 14.64 | 16972261 | |
MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 14.64 | 16972261 | |
MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 2.74 | 14633726 | |
MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 11.60 | 19077051 | |
MESH:D007951 | Leukemia, Myeloid | Retinoids | 11.60 | 16482212 | |
MESH:D007951 | Leukemia, Myeloid | Tretinoin | 11.60 | 16482212 16932348 19285840 | |
MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 4.59 | 19850784 16467208 16968895 20471514 17050201 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 4.59 | 19850784 17596541 16294345 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Valproic Acid | 4.59 | 17596541 16294345 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | Arsenic | 9.07 | 17339181 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 9.07 | 16331271 17869043 11468182 16891316 9834237 19225113 16330433 17217047 16112521 11161223 15748426 15622746 15336539 16966277 12712474 12018890 19035177 15213294 19642359 12679006 17107899 16823087 17712046 17649720 19075265 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 9.07 | 16331271 17361223 17506722 17339181 19029980 16823087 17301526 17294898 16766008 16788101 12679006 19642359 16935935 17649720 19225113 17712046 17368321 17107899 15748426 16891316 19075265 9834237 17217047 16140955 19035177 | |
MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 3.51 | 16882451 | |
MESH:D007984 | Leydig Cell Tumor | perfluorooctanoic acid | 10.03 | 8812269 | |
MESH:D007984 | Leydig Cell Tumor | vinclozolin | 10.03 | 16417039 | |
MESH:D017880 | Limb Deformities, Congenital | methoxyacetic acid | 6.39 | 12805644 15959878 | |
MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 6.39 | 9224671 | |
MESH:D008064 | Lipidoses | Ketoconazole | 3.90 | 17567588 | |
MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 7.83 | 18522880 18665156 19638242 20032147 18407596 | |
MESH:D008103 | Liver Cirrhosis | Phenobarbital | 7.83 | 21047994 | |
MESH:D008103 | Liver Cirrhosis | Plant Extracts | 7.83 | 17157831 | |
MESH:D008106 | Liver Cirrhosis, Experimental | marker/mechanism | 17072980 | ||
MESH:D008106 | Liver Cirrhosis, Experimental | Dimethylnitrosamine | 11.80 | 16544323 18637143 15339415 17534399 18095165 17198567 15298665 16169303 18672772 14726149 15942678 17201889 12918455 18567088 17348192 15504291 17432682 18239293 15842777 18629640 17196135 15798949 16270385 15793283 18364076 16627068 15369754 15744066 15864749 15383259 18371158 15577212 15492853 12925901 17719030 17203207 17724770 15723089 15099470 17881167 15086199 16570917 14709902 16603200 15366600 15138612 15479170 15161499 15571005 14659978 15733078 15591649 17465448 15081153 15067225 17640959 18237412 18210741 17666798 16042886 17036385 15763062 14568256 16009107 14643895 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 11.80 | 14659978 14716833 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 11.80 | 17823541 | |
MESH:D008106 | Liver Cirrhosis, Experimental | pioglitazone | 11.80 | 15052691 16484506 | |
MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 11.80 | 15474484 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Plant Extracts | 11.80 | 15479170 | |
MESH:D008106 | Liver Cirrhosis, Experimental | rosiglitazone | 11.80 | 17347453 15980055 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 11.80 | 12878042 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 11.80 | 18397230 16248980 | |
MESH:D008107 | Liver Diseases | Acetaminophen | 11.41 | 19014921 16610002 12969438 16611625 19460945 19784758 11587558 12587719 | |
MESH:D008107 | Liver Diseases | Arsenic | 11.41 | 11134558 | |
MESH:D008107 | Liver Diseases | Diethylnitrosamine | 11.41 | 17034775 | |
MESH:D008107 | Liver Diseases | Lindane | 11.41 | 1715830 | |
MESH:D008107 | Liver Diseases | Phenobarbital | 11.41 | 19363144 | |
MESH:D008107 | Liver Diseases | Plant Extracts | 11.41 | 17034775 | |
MESH:D017114 | Liver Failure, Acute | Acetaminophen | 7.08 | 17185352 16871587 | |
MESH:D017114 | Liver Failure, Acute | Dimethylnitrosamine | 7.08 | 17457977 | |
MESH:D008113 | Liver Neoplasms | Arsenic | 31.45 | 16368122 | |
MESH:D008113 | Liver Neoplasms | arsenic trioxide | 31.45 | 14682389 | |
MESH:D008113 | Liver Neoplasms | Clofibric Acid | 31.45 | 17602206 | |
MESH:D008113 | Liver Neoplasms | Dehydroepiandrosterone | 31.45 | 18709148 | |
MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 31.45 | 20452335 12112319 19427195 20583210 16942905 18977376 19833225 19499222 21047994 18648771 18644402 15175105 19812893 19254457 18754104 19690152 9163691 19996281 20434301 19294768 19850985 20101389 19256749 19638242 19551842 12771043 2422723 2862719 19090486 21278145 21167192 19255062 19073162 19426721 10737359 20137499 20492335 15885732 20405173 20501860 19642983 18978307 20118626 21071580 | |
MESH:D008113 | Liver Neoplasms | Diethylstilbestrol | 31.45 | 15890375 16712894 | |
MESH:D008113 | Liver Neoplasms | Dimethylnitrosamine | 31.45 | 15890375 3113478 | |
MESH:D008113 | Liver Neoplasms | perfluorooctanoic acid | 31.45 | 14757943 18709148 | |
MESH:D008113 | Liver Neoplasms | Phenobarbital | 31.45 | 8742319 19812893 15975961 21047994 19482888 19073162 | |
MESH:D008113 | Liver Neoplasms | pirinixic acid | 31.45 | 15890375 20007298 16377806 | |
MESH:D008113 | Liver Neoplasms | Plant Extracts | 31.45 | 19168119 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 31.45 | 16984957 | |
MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 15.42 | 20377131 | |
MESH:D008114 | Liver Neoplasms, Experimental | Dehydroepiandrosterone | 15.42 | 8603461 | |
MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 15.42 | 18775883 3124819 19519916 18544905 9362446 18079962 19009564 18093689 16267830 19126423 16842330 21159647 18282651 17174075 19539802 17942915 17854601 2563599 18308698 18253720 18164116 19004024 | |
MESH:D008114 | Liver Neoplasms, Experimental | Dimethylnitrosamine | 15.42 | 15603536 6150874 1848544 | |
MESH:D008114 | Liver Neoplasms, Experimental | Phenobarbital | 15.42 | 1399818 18308698 17172636 6150874 2563599 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 15.42 | 12151625 | |
MESH:D008133 | Long QT Syndrome | arsenic trioxide | 2.65 | 15213294 | |
MESH:D008171 | Lung Diseases | Ozone | 2.74 | 8266340 19066396 | |
MESH:D017563 | Lung Diseases, Interstitial | Valproic Acid | 3.37 | 17228818 | |
MESH:D055370 | Lung Injury | Ozone | 3.01 | 20417186 | |
MESH:D008175 | Lung Neoplasms | Arsenic | 9.62 | 17306315 17976673 19168569 | |
MESH:D008175 | Lung Neoplasms | arsenic trioxide | 9.62 | 11798837 19825857 | |
MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 9.62 | 20970405 21163286 6695378 20512841 | |
MESH:D008175 | Lung Neoplasms | Dimethylnitrosamine | 9.62 | 16061637 11884234 19555203 | |
MESH:D008175 | Lung Neoplasms | Ozone | 9.62 | 7614698 8597069 | |
MESH:D008175 | Lung Neoplasms | Plant Extracts | 9.62 | 20869020 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 9.62 | 11884234 19555203 | |
MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 9.62 | 11807781 | |
MESH:D008180 | Lupus Erythematosus, Systemic | Carbamazepine | 3.24 | 16628512 | |
MESH:D008181 | Lupus Nephritis | Diethylstilbestrol | 4.27 | 15166399 | |
MESH:D008223 | Lymphoma | Diethylstilbestrol | 2.81 | 15700306 | |
MESH:D052801 | Male Urogenital Diseases | Diethylstilbestrol | 4.62 | 16002989 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Dehydroepiandrosterone | 18.94 | 16457693 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 18.94 | 16891317 11807958 17203775 11408345 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 18.94 | 14578162 12929590 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Progesterone | 18.94 | 17203775 11408345 | |
MESH:D008325 | Mammary Neoplasms, Experimental | rosiglitazone | 18.94 | 16827153 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 18.94 | 8985016 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Triclosan | 18.94 | 15358634 | |
MESH:D020149 | Manganese Poisoning | Estradiol | 3.59 | 19453300 | |
MESH:D008415 | Mastocytosis | Retinoids | 5.71 | 16953078 | |
MESH:D008527 | Medulloblastoma | Tretinoin | 2.34 | 17453147 | |
MESH:D008545 | Melanoma | Tretinoin | 1.81 | 16752155 | |
MESH:D008546 | Melanoma, Experimental | Acetaminophen | 2.71 | 19513568 | |
MESH:D008591 | Meningomyelocele | Tretinoin | 3.56 | 16940565 | |
MESH:D008607 | Mental Retardation | Carbamazepine | 3.34 | 9014606 | |
MESH:D024821 | Metabolic Syndrome X | rosiglitazone | 3.63 | 17261469 | |
MESH:D008679 | Metaplasia | Ozone | 4.21 | 10496685 | |
MESH:D008881 | Migraine Disorders | topiramate | 5.81 | 18765137 18803445 16942474 18759728 | |
MESH:D008881 | Migraine Disorders | Valproic Acid | 5.81 | 18765137 18803445 | |
MESH:D019964 | Mood Disorders | etiracetam | 5.48 | 19265183 | |
MESH:D009101 | Multiple Myeloma | arsenic trioxide | 2.45 | 15949261 19417148 14977855 19549372 11468182 | |
MESH:D009135 | Muscular Diseases | pirinixic acid | 2.65 | 16239165 | |
MESH:D009139 | Musculoskeletal Abnormalities | Valproic Acid | 3.23 | 8888407 | |
MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 3.78 | 18349030 | |
MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 8.91 | 16105982 16882451 | |
MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 8.91 | 17596541 | |
MESH:D009190 | Myelodysplastic Syndromes | Valproic Acid | 8.91 | 17596541 | |
MESH:D009203 | Myocardial Infarction | Genistein | 4.12 | 17141266 | |
MESH:D009203 | Myocardial Infarction | pirinixic acid | 4.12 | 19151258 | |
MESH:D017202 | Myocardial Ischemia | Arsenic | 6.57 | 15371236 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 6.57 | 12213967 | |
MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 10.05 | 16810080 | |
MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 10.05 | 17141266 | |
MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 10.05 | 16411023 | |
MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenobarbital | 3.60 | 17484760 | |
MESH:D020190 | Myoclonic Epilepsy, Juvenile | etiracetam | 5.16 | 19265183 | |
MESH:D009224 | Myotonia Congenita | Carbamazepine | 4.59 | 20399394 | |
MESH:D009336 | Necrosis | 2,4-dinitrotoluene | 2.99 | 18551238 | |
MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 3.12 | 16624393 | |
MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 2.14 | 3581430 9029167 | |
MESH:D009369 | Neoplasms | Diethylstilbestrol | 7.60 | 15313581 | |
MESH:D009369 | Neoplasms | Lindane | 7.60 | 12807735 16818664 | |
MESH:D009369 | Neoplasms | pirinixic acid | 7.60 | 17405874 | |
MESH:D009369 | Neoplasms | Tretinoin | 7.60 | 16594593 16946489 | |
MESH:D009389 | Neovascularization, Pathologic | Estradiol | 2.86 | 17289903 | |
MESH:D009395 | Nephritis, Interstitial | Tetracycline | 3.90 | 9884423 | |
MESH:D009421 | Nervous System Malformations | bisphenol A | 33.41 | 11399458 16427766 | |
MESH:D009421 | Nervous System Malformations | Carbamazepine | 33.41 | 16990009 | |
MESH:D009421 | Nervous System Malformations | Diethylstilbestrol | 33.41 | 11399458 | |
MESH:D009421 | Nervous System Malformations | Estradiol | 33.41 | 16427766 11399458 | |
MESH:D009421 | Nervous System Malformations | Genistein | 33.41 | 16427766 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 33.41 | 14600291 | |
MESH:D009421 | Nervous System Malformations | Tretinoin | 33.41 | 9125849 | |
MESH:D009436 | Neural Tube Defects | Arsenic | 12.12 | 16620997 | |
MESH:D009436 | Neural Tube Defects | arsenic trioxide | 12.12 | 10525206 | |
MESH:D009436 | Neural Tube Defects | Tretinoin | 12.12 | 9142499 | |
MESH:D009436 | Neural Tube Defects | Valproic Acid | 12.12 | 8888407 16359493 | |
MESH:D019954 | Neurobehavioral Manifestations | Plant Extracts | 4.32 | 17168769 | |
MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 5.72 | 18514411 | |
MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 5.72 | 20387270 | |
MESH:D020078 | Neurogenic Inflammation | Arsenic | 3.56 | 17056641 | |
MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 4.22 | 20387270 | |
MESH:D052556 | Niemann-Pick Disease, Type C | Cholesterol | 9.49 | 9802331 20557099 | |
MESH:D052556 | Niemann-Pick Disease, Type C | perfluorooctanoic acid | 9.49 | 9802331 | |
MESH:D009765 | Obesity | pirinixic acid | 3.68 | 20558911 | |
MESH:D009765 | Obesity | Plant Extracts | 3.68 | 19056576 20132043 | |
MESH:D009784 | Occupational Diseases | 2,4-dinitrotoluene | 2.66 | 16049721 12819281 | |
MESH:D010018 | Osteomalacia | Carbamazepine | 9.19 | 17016548 | |
MESH:D010018 | Osteomalacia | Phenobarbital | 9.19 | 17016548 | |
MESH:D010024 | Osteoporosis | Genistein | 5.55 | 19401787 | |
MESH:D010024 | Osteoporosis | Isoflavones | 5.55 | 16562857 | |
MESH:D015663 | Osteoporosis, Postmenopausal | Dehydroepiandrosterone | 7.72 | 16397352 | |
MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 7.72 | 16169203 | |
MESH:D010049 | Ovarian Diseases | bisphenol A | 4.11 | 11985600 | |
MESH:D010051 | Ovarian Neoplasms | Arsenic | 13.78 | 17306315 | |
MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 13.78 | 19769630 12452020 16624393 | |
MESH:D010051 | Ovarian Neoplasms | Estradiol | 13.78 | 19401270 | |
MESH:D010051 | Ovarian Neoplasms | Genistein | 13.78 | 19005980 | |
MESH:D010051 | Ovarian Neoplasms | Progesterone | 13.78 | 16525653 17393432 | |
MESH:D010051 | Ovarian Neoplasms | Tretinoin | 13.78 | 16936753 | |
MESH:D010146 | Pain | Acetaminophen | 7.14 | 16870215 | |
MESH:D010146 | Pain | Carbamazepine | 7.14 | 15215642 | |
MESH:D010146 | Pain | Tretinoin | 7.14 | 16870215 | |
MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 11.77 | 15580305 | |
MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 11.77 | 16540662 | |
MESH:D010190 | Pancreatic Neoplasms | Phenobarbital | 11.77 | 16965848 | |
MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 11.77 | 15976015 | |
MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 11.77 | 15976015 | |
MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 8.70 | 11578682 | |
MESH:D016584 | Panic Disorder | etiracetam | 8.70 | 19265183 | |
MESH:D010212 | Papilloma | Plant Extracts | 6.94 | 15173996 16517061 | |
MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 6.94 | 8330346 12065085 18404319 18922899 | |
MESH:D010235 | Paraganglioma | arsenic trioxide | 3.34 | 19927285 | |
MESH:D010267 | Parapsoriasis | Carbamazepine | 4.84 | 16538176 | |
OMIM:167400 | PAROXYSMAL EXTREME PAIN DISORDER | Carbamazepine | 5.04 | 17145499 17679678 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 3.35 | 12520081 | |
MESH:D010391 | Pemphigoid, Bullous | Tetracycline | 4.54 | 11026799 | |
MESH:D010523 | Peripheral Nervous System Diseases | Arsenic | 3.35 | 16093927 | |
MESH:D016491 | Peripheral Vascular Diseases | Arsenic | 4.11 | 6392382 15371236 16905509 | |
MESH:D010538 | Peritonitis | Ozone | 3.28 | 16369182 | |
MESH:D010900 | Pituitary Diseases | Diethylstilbestrol | 4.27 | 14722030 | |
MESH:D010911 | Pituitary Neoplasms | Diethylstilbestrol | 3.81 | 15687265 16977796 | |
MESH:D011014 | Pneumonia | Ozone | 3.52 | 18381685 18929643 18007984 | |
MESH:D011085 | Polycystic Ovary Syndrome | Flutamide | 4.21 | 15356085 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 2.72 | 18163543 | |
MESH:D011230 | Precancerous Conditions | Corn Oil | 11.12 | 14668109 | |
MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 11.12 | 2563599 | |
MESH:D011230 | Precancerous Conditions | Phenobarbital | 11.12 | 2563599 | |
MESH:D011248 | Pregnancy Complications | Carbamazepine | 4.30 | 9014606 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 32.35 | 10548101 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Carbamazepine | 32.35 | 9014606 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Diethylstilbestrol | 32.35 | 17184923 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | perfluorooctanoic acid | 32.35 | 17132714 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 32.35 | 11222880 11118676 11399792 11896295 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Valproic Acid | 32.35 | 20603192 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | vinclozolin | 32.35 | 18220299 18042343 19015723 | |
MESH:D017096 | Prion Diseases | Tetracycline | 4.53 | 10903871 | |
MESH:D011469 | Prostatic Diseases | vinclozolin | 4.05 | 18220299 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 13.43 | 20887781 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 13.43 | 20887781 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | Testosterone | 13.43 | 20887781 | |
MESH:D011471 | Prostatic Neoplasms | marker/mechanism | 15538743 16424004 16859836 16998812 17592021 | ||
MESH:D011471 | Prostatic Neoplasms | Androgens | 5.40 | 15389811 17909013 16998812 | |
MESH:D011471 | Prostatic Neoplasms | Arsenic | 5.40 | 16140617 | |
MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 5.40 | 19131511 | |
MESH:D011471 | Prostatic Neoplasms | bisphenol A | 5.40 | 16740699 | |
MESH:D011471 | Prostatic Neoplasms | Diethylstilbestrol | 5.40 | 17136230 15846301 15046698 | |
MESH:D011471 | Prostatic Neoplasms | Estradiol | 5.40 | 16740699 | |
MESH:D011471 | Prostatic Neoplasms | Estrogens, Catechol | 5.40 | 17261777 | |
MESH:D011471 | Prostatic Neoplasms | Flutamide | 5.40 | 3169114 | |
MESH:D011471 | Prostatic Neoplasms | Genistein | 5.40 | 15256057 15378649 16925846 | |
MESH:D011471 | Prostatic Neoplasms | Isoflavones | 5.40 | 17374662 17571952 16365062 17219775 | |
MESH:D011471 | Prostatic Neoplasms | Ketoconazole | 5.40 | 17404083 | |
MESH:D011471 | Prostatic Neoplasms | Lindane | 5.40 | 14688026 12661182 | |
MESH:D011471 | Prostatic Neoplasms | Plant Extracts | 5.40 | 17804756 14666653 | |
MESH:D011471 | Prostatic Neoplasms | Retinoids | 5.40 | 16166285 16724957 | |
MESH:D011472 | Prostatitis | vinclozolin | 4.05 | 18629315 | |
MESH:D011507 | Proteinuria | Arsenic | 10.94 | 21343184 | |
MESH:D011507 | Proteinuria | pioglitazone | 10.94 | 16687628 | |
MESH:D011507 | Proteinuria | Tretinoin | 10.94 | 16636307 | |
MESH:D011537 | Pruritus | Ethinyl Estradiol | 2.45 | 15861022 16919318 | |
MESH:D019310 | Pseudolymphoma | Carbamazepine | 16.03 | 9591791 12752131 | |
MESH:D019310 | Pseudolymphoma | Phenobarbital | 16.03 | 12752131 | |
MESH:D019310 | Pseudolymphoma | Valproic Acid | 16.03 | 11422049 12752131 | |
MESH:D011625 | Pterygium | Tretinoin | 3.91 | 16723453 | |
MESH:D011629 | Puberty, Precocious | bisphenol A | 3.91 | 10548101 | |
MESH:D011658 | Pulmonary Fibrosis | tetrathiomolybdate | 5.43 | 12624602 15541506 | |
MESH:D011658 | Pulmonary Fibrosis | troglitazone | 5.43 | 18162602 | |
MESH:D015427 | Reperfusion Injury | pirinixic acid | 1.88 | 19058328 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.99 | 18990726 | |
MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 8.14 | 16283617 16116481 | |
MESH:D012208 | Rhabdomyosarcoma | Valproic Acid | 8.14 | 19155313 | |
MESH:D012468 | Salivary Gland Neoplasms | Progesterone | 2.45 | 18045962 | |
MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 3.12 | 16646077 | |
MESH:D012559 | Schizophrenia | Valproic Acid | 1.92 | 19110320 15737665 | |
MESH:D012640 | Seizures | 2,4-dinitrotoluene | 21.76 | 18551238 | |
MESH:D012640 | Seizures | Carbamazepine | 21.76 | 16180713 16938433 9844417 15946322 16876388 19414003 9046859 | |
MESH:D012640 | Seizures | etiracetam | 21.76 | 15946322 11738929 | |
MESH:D012640 | Seizures | lamotrigine | 21.76 | 16499746 9844417 | |
MESH:D012640 | Seizures | Lindane | 21.76 | 7539098 12842176 15475178 | |
MESH:D012640 | Seizures | Phenobarbital | 21.76 | 3137016 16876388 4039156 11442880 | |
MESH:D012640 | Seizures | topiramate | 21.76 | 16499746 | |
MESH:D012640 | Seizures | Valproic Acid | 21.76 | 11738929 15475178 1511512 17978042 3137016 14763951 11044598 16876388 | |
MESH:D003294 | Seizures, Febrile | Phenobarbital | 3.94 | 6407741 | |
OMIM:608579 | SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO | lamotrigine | 5.73 | 20485159 19668019 | |
MESH:D012735 | Sexual Dysfunction, Physiological | Testosterone | 5.31 | 16631401 | |
MESH:D012871 | Skin Diseases | Arsenic | 4.27 | 19834688 15952646 6392382 17050553 16702368 18709164 16759981 17938729 17548696 16353154 17453740 | |
MESH:D012871 | Skin Diseases | monomethylarsonous acid | 4.27 | 17431481 | |
MESH:D012878 | Skin Neoplasms | Arsenic | 15.86 | 17050553 19538983 16251483 15504454 17029826 17976673 | |
MESH:D012878 | Skin Neoplasms | Plant Extracts | 15.86 | 15173996 16517061 | |
MESH:D012878 | Skin Neoplasms | Retinoids | 15.86 | 17538947 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 15.86 | 16192470 | |
MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 15.86 | 11807781 8330346 8985016 18404319 12065085 | |
MESH:D012878 | Skin Neoplasms | Tretinoin | 15.86 | 16467112 | |
MESH:D012893 | Sleep Disorders | Carbamazepine | 4.25 | 19414003 | |
MESH:D013088 | Spermatocele | Diethylstilbestrol | 8.76 | 16709447 16002989 | |
MESH:D013088 | Spermatocele | Ethinyl Estradiol | 8.76 | 16709447 | |
MESH:D013119 | Spinal Cord Injuries | Progesterone | 3.41 | 15862959 16503802 | |
MESH:D016135 | Spinal Dysraphism | Valproic Acid | 3.06 | 19490988 | |
MESH:D013158 | Splenic Diseases | Dimethylnitrosamine | 4.38 | 12587719 | |
MESH:D013226 | Status Epilepticus | Valproic Acid | 3.65 | 12833885 | |
MESH:D013262 | Stevens-Johnson Syndrome | Carbamazepine | 9.07 | 18855540 15057820 16415921 16538176 20485159 19694795 19915237 | |
MESH:D013262 | Stevens-Johnson Syndrome | lamotrigine | 9.07 | 20235791 | |
MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 4.77 | 17007042 | |
MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 4.77 | 18456281 | |
MESH:D013274 | Stomach Neoplasms | Dimethylnitrosamine | 4.77 | 16033868 | |
MESH:D013274 | Stomach Neoplasms | Tretinoin | 4.77 | 17261132 | |
MESH:D013274 | Stomach Neoplasms | troglitazone | 4.77 | 15930296 | |
MESH:D013276 | Stomach Ulcer | olive oil | 5.49 | 12498302 16252198 | |
MESH:D013276 | Stomach Ulcer | Plant Extracts | 5.49 | 17135157 12787963 15255614 18237397 18193104 | |
MESH:D019966 | Substance-Related Disorders | bisphenol A | 3.12 | 16045194 16684133 | |
MESH:D013576 | Syndactyly | methoxyacetic acid | 4.79 | 1761404 1761407 | |
MESH:D013705 | Temporomandibular Joint Disorders | Plant Extracts | 4.59 | 17997062 | |
MESH:D013733 | Testicular Diseases | methoxyacetic acid | 8.10 | 18486176 6499806 | |
MESH:D013733 | Testicular Diseases | pyrazole | 8.10 | 6499806 | |
MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.80 | 11994571 | |
MESH:D013927 | Thrombosis | Ethinyl Estradiol | 2.40 | 15669648 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 9.54 | 12697716 | |
MESH:D013959 | Thyroid Diseases | Triclosan | 9.54 | 19910387 | |
MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 15.08 | 19014326 | |
MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 15.08 | 7505956 | |
MESH:D013964 | Thyroid Neoplasms | Phenobarbital | 15.08 | 1399818 | |
MESH:D013964 | Thyroid Neoplasms | Retinoids | 15.08 | 16940797 | |
MESH:D013964 | Thyroid Neoplasms | Tretinoin | 15.08 | 17045167 16026305 | |
MESH:D013978 | Tibial Fractures | Estradiol | 3.79 | 19048282 | |
MESH:D014062 | Tongue Neoplasms | Tretinoin | 3.01 | 16051514 | |
MESH:D016171 | Torsades de Pointes | arsenic trioxide | 3.09 | 15213294 | |
MESH:D005879 | Tourette Syndrome | etiracetam | 5.59 | 19265183 | |
MESH:D014178 | Translocation, Genetic | Valproic Acid | 4.34 | 17262798 | |
MESH:D014376 | Tuberculosis | Tretinoin | 2.61 | 16040207 | |
MESH:D020194 | Unverricht-Lundborg Syndrome | Valproic Acid | 3.64 | 3119515 | |
MESH:D001749 | Urinary Bladder Neoplasms | 2,4-dinitrotoluene | 11.02 | 16049721 | |
MESH:D001749 | Urinary Bladder Neoplasms | Arsenic | 11.02 | 19322015 15987713 11144890 18640142 17306315 19429237 17976673 | |
MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 11.02 | 12845720 12973940 20435036 11780464 | |
MESH:D001749 | Urinary Bladder Neoplasms | Diethylstilbestrol | 11.02 | 16452187 17306315 16712894 | |
MESH:D001749 | Urinary Bladder Neoplasms | monomethylarsonous acid | 11.02 | 20375083 | |
MESH:D014564 | Urogenital Abnormalities | Valproic Acid | 3.78 | 8888407 | |
MESH:D014571 | Urologic Neoplasms | 2,4-dinitrotoluene | 3.44 | 10091137 | |
MESH:D014581 | Urticaria | Acetaminophen | 2.17 | 10982225 | |
MESH:D002583 | Uterine Cervical Neoplasms | Diethylstilbestrol | 6.92 | 16175088 | |
MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 6.92 | 16129372 | |
MESH:D014591 | Uterine Diseases | bisphenol A | 10.85 | 14652134 | |
MESH:D014591 | Uterine Diseases | Diethylstilbestrol | 10.85 | 14652134 | |
MESH:D014594 | Uterine Neoplasms | Diethylstilbestrol | 6.70 | 15809267 16690809 | |
MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 6.70 | 14692618 | |
MESH:D014604 | Uveal Neoplasms | Tretinoin | 3.72 | 16752155 | |
MESH:D014625 | Vaginal Neoplasms | Diethylstilbestrol | 3.58 | 16002989 16513791 | |
MESH:D014652 | Vascular Diseases | Arsenic | 3.86 | 17056641 | |
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.70 | 12125929 | |
MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 2.74 | 14671159 15869587 | |
MESH:D018487 | Ventricular Dysfunction, Left | Plant Extracts | 3.89 | 18097624 | |
MESH:D020257 | Ventricular Remodeling | Plant Extracts | 4.44 | 18097624 | |
MESH:D014820 | Vitiligo | Tretinoin | 3.22 | 16761959 | |
MESH:D014839 | Vomiting | etiracetam | 5.32 | 17157078 | |
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 3.35 | 15886252 | |
MESH:D015431 | Weight Loss | tetrathiomolybdate | 5.65 | 12624602 | |
MESH:D009396 | Wilms Tumor | Tretinoin | 3.20 | 16287080 | |
MESH:D014947 | Wounds and Injuries | Estrogens | 10.36 | 11172683 | |
MESH:D014947 | Wounds and Injuries | Plant Extracts | 10.36 | 19894650 20213670 | |
MESH:D014947 | Wounds and Injuries | sphingosine 1-phosphate | 10.36 | 15541073 |
Pathway ID | Pathway Name |
---|---|
REACT:13433 | Biological oxidations |
REACT:15314 | Hormone biosynthesis |
KEGG:01100 | Metabolic pathways |
REACT:22258 | Metabolism of lipids and lipoproteins |
KEGG:00140 | Steroid hormone biosynthesis |
Drugbank ID | Action | Drug Name | Description |
---|---|---|---|
DB00157 | - | NADH | Dietary supplement;Micronutrient |
DB00396 | inhibitor | Synovex S | Contraceptives;Progestins |
Drugbank ID | Action | Drug Name | Description |
---|---|---|---|
DB00396 | inhibitor | Synovex S | Contraceptives;Progestins |
DB01233 | inhibitor | Metoclopramide | Antiemetics;Dopamine Antagonists;Prokinetic Agents |
DB01234 | inhibitor | Tresaderm Dermatologic Solution | Anti-inflammatory Agents;Adrenergic Agents;Antiemetics;Antineoplastic Agents, Hormonal;Glucocorticoids |
DB01424 | substrate | Aminophenazone | Analgesics;Pyrazolones |
DB02901 | substrate | Dihydrotestosterone | Androgens;Steroidal |
DB04630 | inducer | Aldosterone |
No data |
No data |